Lawmakers probe FDA’s new priority voucher program, cite corruption and rushed review concerns
As the FDA’s Commissioner’s National Priority Voucher (CNPV) program has picked up steam, with 15 companies now having secured ultrafast drug reviews, questions and criticisms about the initiative have been…